Cite
MLA Citation
R. Bartsch et al.. “P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib.” Breast, vol. 68, 2023, pp. S20–S21. http://access.bl.uk/ark:/81055/vdc_100180204870.0x00002e